MLR Review Software: The Complete Landscape (2026)
Updated 2026-07-13 · markdown version
MLR review software manages the medical, legal, and regulatory review of pharmaceutical promotional and medical materials — routing deliverables to reviewers, tracking claims against their supporting references, and producing the audit trail regulators expect. In 2026 the category spans three distinct layers: workflow systems of record (Veeva Vault PromoMats, Vodori Pepper Flow), collaborative review tools (Papercurve), and AI pre-review assistants that check content before it enters formal review (Lithero, Revisto, Claims).
Why this landscape is confusing
There is no clean "MLR review software" category on G2 or Capterra. Veeva Vault PromoMats — the de facto industry system of record — is filed under Digital Asset Management, which is why generic "alternatives" listicles surface irrelevant DAM tools like Bynder and Brandfolder next to pharma review platforms. Market-size figures are equally noisy: analyst estimates for the segment range from $13.1B (2025) growing to $27.1B by 2032 (ResearchAndMarkets) to ~$17B growing to ~$42B by 2035 (Precedence, via Shaman) — treat all of them as directional vendor/analyst PR rather than audited numbers.
The practical way to map the space is by when the tool touches your content:
| Layer | What it does | Representative tools |
|---|---|---|
| System of record | Formal routing, e-signatures, claim libraries, FDA Form 2253 submission support, archival | Veeva Vault PromoMats; Vodori Pepper Flow |
| Collaborative review | Lighter-weight review, commenting, version control for teams that find Vault heavy | Papercurve |
| AI pre-review / assistant | Reads content against references and rules before formal review; flags unsupported claims, missing fair balance, drift | Lithero LARA; Revisto; SecureCHEK AI; Claims (medcom.claims) |
| Services-led | Outsourced MLR operations with tooling attached | EVERSANA ORCHESTRATE; Indegene |
The tools, briefly and honestly
Veeva Vault PromoMats — the incumbent system of record for promotional review in large and mid pharma. Deep claim-library and 2253 functionality, extensive validation. Its weight is the common complaint that drives the "alternatives" search (see our pharma-accurate alternatives guide).
Vodori (Pepper Flow) — a purpose-built promotional review platform positioned directly against Vault for speed and usability; actively publishes "Vodori vs Veeva" comparison content.
Papercurve — collaborative content review for life sciences; markets a "60% faster review" figure (vendor claim).
Lithero (LARA) — AI review assistant founded 2015; positions against "claims matrix spreadsheets" and checks drafts for compliance issues pre-submission.
Revisto — AI-native MLR platform based in Austin, TX; raised a $4M seed round in November 2024 led by LiveOak Ventures with participation from Eli Lilly and Company (Business Wire, Nov 18, 2024), bringing total funding to $6M. Markets "90% review-cycle reduction" (vendor claim).
SecureCHEK AI — AI compliance pre-check for promotional material; markets "70% faster" review (vendor claim).
Claims (medcom.claims) — our tool, so read this entry with that in mind. Claims takes a different angle from all of the above: it lives with the writer, inside Word and PowerPoint, rather than in the review committee's workflow system. Every claim is deep-linked to the page/column/paragraph of its supporting reference at writing time; an agentic MLR pre-review then reads each claim against that evidence and flags overreach, drift, and unsupported statements before the deliverable ever enters formal MLR. It is sourced-only by design — a claim cannot ship without evidence that exists in the writer's own references. Currently in design-partner pilot with working medical writers.
How to choose
- You are a regulatory/ops leader at mid-to-large pharma: you need a system of record. Evaluate Vault PromoMats and Vodori; the AI layer comes after.
- Your bottleneck is review cycles, not routing: the AI pre-review layer is where the time actually comes back. Fewer findings entering committee = fewer rounds. This is the layer where Lithero, Revisto, and Claims compete.
- You are a medical writer or freelancer: systems of record are bought by your clients, not you. A writer-side tool that keeps your claims substantiated and annotated (and catches problems before the client's MLR does) is the layer you can actually adopt yourself — this is precisely who Claims is built for.
The metric that matters
Whatever you evaluate, benchmark one number: review rounds per deliverable. Industry anecdote puts typical promotional pieces at 2–3+ MLR rounds; every round is calendar weeks and reviewer goodwill. A tool earns its keep by converting round 2 into round 1 — either by better workflow (systems of record) or by catching the findings before round 1 starts (pre-review assistants).
Vendor performance figures above ("90% faster," "60% faster," "70% faster") are marketing claims from the respective vendors, not independently audited results. We label ours the same way: in pilot, our goal is saving one full review-revision cycle per deliverable — we'll publish real numbers from pilot data when we have them.